Lisata Therapeutics, Inc.

LSTA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$4-$5-$5-$5
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$1$1
Change in WC$1$0-$1$0
Other Non-Cash$0$0-$0-$1
Operating Cash Flow-$3-$4-$5-$5
Investing Activities
PP&E Inv.$0-$0-$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0-$4-$5-$12
Inv. Sales/Matur.$5$5$15$13
Other Inv. Act.$0$0$0-$0
Investing Cash Flow$5$1$9$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$0-$0-$0
Financing Cash Flow$0$0-$0-$0
Forex Effect$0$0$0-$0
Net Chg. in Cash$2-$3$4-$3
Supplemental Information
Beg. Cash$17$20$16$20
End Cash$19$17$20$16
Free Cash Flow-$3-$4-$5-$5
Lisata Therapeutics, Inc. (LSTA) Financial Statements & Key Stats | AlphaPilot